This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Young, D. Z. Articles by Lown, B. Search for Related Content PubMed PubMed Citation Articles by Young, D. Z. Articles by Lown, B. Pubmed/NCBI databases Medline Plus Health Information Arrhythmia

Circulation, Vol 70, 184-191, Copyright © 1984 by American Heart Association

ARTICLES

Safety of maximal exercise testing in patients at high risk for ventricular arrhythmia

DZ Young, S Lampert, TB Graboys and B Lown

While maximal exercise testing is useful for detection of arrhythmias and assessment of antiarrhythmic drug efficacy, few reports have documented the safety of this procedure in patients with malignant ventricular arrhythmias. We reviewed the complications of symptom- limited exercise in 263 patients with such arrhythmias who underwent a total of 1377 maximal treadmill tests. Seventy-four percent of the population studied had a history of ventricular fibrillation or hemodynamically compromising ventricular tachycardia and the remainder had experienced ventricular tachycardia in the setting of either recent myocardial infarction or poor left ventricular function. A complication was defined as the occurrence of arrhythmia during exercise testing-- ventricular fibrillation, ventricular tachycardia, or bradycardia--that mandated immediate medical treatment (cardioversion, use of intravenous drugs, or closed-chest compression). Complications were noted in 24 patients (9.1%) during 32 tests (2.3%), whereas 239 patients (90.9%) were free of complication during 1345 tests (97.7%). There were no deaths, myocardial infarctions, or lasting morbid events. Clinical descriptors associated with complications included male sex, presence of coronary artery disease, and a history of exertional arrhythmia (p less than .05). Clinical variables previously considered to confer increased risk during exercise, such as poor left ventricular function, high-grade ventricular arrhythmias (Lown grade 4A or 4B) before or during exercise, exertional hypotension, and ST depression, were not predictive of complications (p greater than .05). Occurrence of a complication was also unaffected by the use of antiarrhythmic drugs at the time of exercise (chi square = 0.19, p greater than .05).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346. [Full Text] [PDF]

				Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 746 - 837. [Full Text] [PDF]

				L. Vanhees, M. Kornaat, J. Defoor, G. Aufdemkampe, D. Schepers, A. Stevens, H. van Exel, J. van den Beld, H. Heidbuchel, and R. Fagard Effect of exercise training in patients with an implantable cardioverter defibrillator Eur. Heart J., July 1, 2004; 25(13): 1120 - 1126. [Abstract] [Full Text] [PDF]

				A Fitchet, P J Doherty, C Bundy, W Bell, A P Fitzpatrick, and C J Garratt Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial Heart, February 1, 2003; 89(2): 155 - 160. [Abstract] [Full Text] [PDF]

				M. E. Tavel Stress Testing in Cardiac Evaluation : Current Concepts With Emphasis on the ECG Chest, March 1, 2001; 119(3): 907 - 925. [Full Text] [PDF]

				D. M. Shahian, W. A. Williamson, F. J. Venditti Jr., D. T. Martin, and J. R. Ellis THE ROLE OF CORONARY REVASCULARIZATION IN RECIPIENTS OF AN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR J. Thorac. Cardiovasc. Surg., October 1, 1995; 110(4): 1013 - 1022. [Abstract] [Full Text]

				I. L. Pina, G. J. Balady, P. Hanson, A. J. Labovitz, D. W. Madonna, and J. Myers Guidelines for Clinical Exercise Testing Laboratories : A Statement for Healthcare Professionals From the Committee on Exercise and Cardiac Rehabilitation, American Heart Association Circulation, February 1, 1995; 91(3): 912 - 921. [Full Text]